NYSE:AMPE

Ampio Pharmaceuticals Stock News

> Biotechnology

Buy AMPE

*Your capital is at risk

$0.183

+0 (+0%)

At Close: Jun 03, 2026

Ampio Pharma shares down 61% after the FDA said the company's trial for AP-0003-C was not adequate. The FDA is recommending Ampio performs a randomized trial

12:00am, Tuesday, 07'th Aug 2018

66 Biggest Movers From Friday

12:00am, Monday, 06'th Aug 2018

'Someone is paying for a new $AMPE stock promotion campaign on Twitter, Seeking Alpha, message boards and web sites like below:'-STAT's Adam Feuerstein Tweets

12:00am, Friday, 27'th Jul 2018

38 Biggest Movers From Yesterday

12:00am, Tuesday, 24'th Jul 2018

41 Biggest Movers From Friday

12:00am, Monday, 23'rd Jul 2018

Ampio up 12% on rumored takeover

12:00am, Friday, 20'th Jul 2018

Ampio Pharmaceuticals Shares Up 15.7% For Session Despite No Company-Specific News Or Fundamental Catalyst To Justify Price Action; Watch For Technical Indicators And Price Action

12:00am, Friday, 22'nd Jun 2018

Analysts Remain Bullish on Flexion Therapeutics

12:00am, Tuesday, 12'th Jun 2018

Ampio Announces 2 Peer-Reviewed Articles ON Clinical Application Of Ampion

12:00am, Tuesday, 05'th Jun 2018

Your Daily Pharma Scoop: 4 NDAs. CPRX, EXEL, ALPMY, ACOR

12:00am, Thursday, 31'st May 2018

42 Biggest Movers From Yesterday

12:00am, Wednesday, 30'th May 2018

Ampio Awarded U.S. Patent For Treatment Of Joint Conditions That Provides Method Protection Until 2035 For Multiple Injections Of Ampion

12:00am, Tuesday, 29'th May 2018

Warrant You Glad You're Not Long Ampio?

12:00am, Tuesday, 15'th May 2018

Ampio Pharmaceuticals Stock News

Ampio Pharma shares down 61% after the FDA said the company's trial for AP-0003-C was not adequate. The FDA is recommending Ampio performs a randomized trial

66 Biggest Movers From Friday

'Someone is paying for a new $AMPE stock promotion campaign on Twitter, Seeking Alpha, message boards and web sites like below:'-STAT's Adam Feuerstein Tweets

38 Biggest Movers From Yesterday

41 Biggest Movers From Friday

Ampio up 12% on rumored takeover

Ampio Pharmaceuticals Shares Up 15.7% For Session Despite No Company-Specific News Or Fundamental Catalyst To Justify Price Action; Watch For Technical Indicators And Price Action

Analysts Remain Bullish on Flexion Therapeutics

Ampio Announces 2 Peer-Reviewed Articles ON Clinical Application Of Ampion

Your Daily Pharma Scoop: 4 NDAs. CPRX, EXEL, ALPMY, ACOR

42 Biggest Movers From Yesterday

Ampio Awarded U.S. Patent For Treatment Of Joint Conditions That Provides Method Protection Until 2035 For Multiple Injections Of Ampion

Warrant You Glad You're Not Long Ampio?

UPDATE: Ampio Says Is Actively Pursuing Endeavors To Strengthen Its Balance Sheet

36 Biggest Movers From Yesterday

Top Fintech Company